Cargando…

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study

Treatment-resistant depression (TRD) reduces affected patients’ quality of life and leads to important social health care costs. Pharmacogenomics-guided treatment (PGT) may be effective in the cure of TRD. The main aim of this study was to evaluate the clinical changes after PGT in patients with TRD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Casale, Antonio, Pomes, Leda Marina, Bonanni, Luca, Fiaschè, Federica, Zocchi, Clarissa, Padovano, Alessio, De Luca, Ottavia, Angeletti, Gloria, Brugnoli, Roberto, Girardi, Paolo, Preissner, Robert, Borro, Marina, Gentile, Giovanna, Pompili, Maurizio, Simmaco, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874425/ https://www.ncbi.nlm.nih.gov/pubmed/35207804 http://dx.doi.org/10.3390/jpm12020316

Ejemplares similares

Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders
por: del Casale, Antonio, et al.
Publicado: (2022)

Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms
por: Del Casale, Antonio, et al.
Publicado: (2020)

Individualized Drugs’ Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process
por: Borro, Marina, et al.
Publicado: (2021)

Optimising migraine treatment: from drug-drug interactions to personalized medicine
por: Pomes, Leda Marina, et al.
Publicado: (2019)

Frequencies of Combined Dysfunction of Cytochromes P450 2C9, 2C19, and 2D6 in an Italian Cohort: Suggestions for a More Appropriate Medication Prescribing Process
por: Gentile, Giovanna, et al.
Publicado: (2023)

Current Clinical Psychopharmacology in Borderline Personality Disorder
por: Del Casale, Antonio, et al.
Publicado: (2021)

DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs
por: Del Casale, Antonio, et al.
Publicado: (2023)

Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2
por: Borro, Marina, et al.
Publicado: (2020)

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Pompili, Maurizio, et al.
Publicado: (2008)

Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN(®) System Comprehensive Approach
por: Roberto, Michela, et al.
Publicado: (2021)

Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
por: Del Casale, Antonio, et al.
Publicado: (2019)

Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
por: De Luca, Ottavia, et al.
Publicado: (2022)

Drug Treatment of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia)
por: Sani, Gabriele, et al.
Publicado: (2019)

Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015)

MRI predictors of pharmacotherapy response in major depressive disorder
por: Gerlach, Andrew R., et al.
Publicado: (2022)

Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time
por: Kotzalidis, Georgios D., et al.
Publicado: (2019)

Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach
por: Koverech, Angela, et al.
Publicado: (2018)

Study of the efficacy and safety of various pharmacotherapy regimens for atypical depression in the framework of bipolar affective disorder, recurrent depressive disorder, psychogenic depression
por: Verbitskaya, M., et al.
Publicado: (2022)

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Neural Implications of Psychotherapy, Pharmacotherapy, and Combined Treatment in Major Depressive Disorder
por: Schwartz, Thomas L., et al.
Publicado: (2016)

The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
por: Arnaud, Alix, et al.
Publicado: (2021)

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
por: Wolff, Jan, et al.
Publicado: (2021)

Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study.()
por: Lionetto, Luana, et al.
Publicado: (2021)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

The pharmacotherapy of depression with EPA
por: Puri, Basant K
Publicado: (2010)

Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
por: Cosci, Fiammetta, et al.
Publicado: (2021)

Validation of a small-size pooling approach targeting hospital surveillance of SARS-CoV-2 infection
por: Petrucca, Andrea, et al.
Publicado: (2020)

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care
por: Saya, Sibel, et al.
Publicado: (2023)

Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort
por: Mazzuca, Federica, et al.
Publicado: (2016)

Pandemic experiences and psychopathological aspects in individuals with mood disorders and other mental disorders
por: Del Casale, Antonio, et al.
Publicado: (2022)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Loh, Feng-Hua, et al.
Publicado: (2021)

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality
por: AL-Taie, Anmar, et al.
Publicado: (2022)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression
por: Luca, Antonina, et al.
Publicado: (2013)

Short-Term Psychodynamic Psychotherapy in Patients with “Male Depression” Syndrome, Hopelessness, and Suicide Risk: A Pilot Study
por: Angeletti, Gloria, et al.
Publicado: (2013)

SARS-CoV-2 Transmission Control Measures in the Emergency Department: The Role of Rapid Antigenic Testing in Asymptomatic Subjects
por: Borro, Marina, et al.
Publicado: (2022)

Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
por: Borro, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8i6mcnq77vttimlhrhb4q5hcbu